发布求助
文献互助 智能选刊 最新文献

使用CRISPR/Cas9技术生成抗cd5 CAR敲入的人诱导多能干细胞系

IF 0.8 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Stem cell research Pub Date : 2025-05-06 DOI:10.1016/j.scr.2025.103731
Shuoting Wang , Xinrui Guo , Han Yan , Tiancheng Zhou , Jiajun Liu
{"title":"使用CRISPR/Cas9技术生成抗cd5 CAR敲入的人诱导多能干细胞系","authors":"Shuoting Wang ,&nbsp;Xinrui Guo ,&nbsp;Han Yan ,&nbsp;Tiancheng Zhou ,&nbsp;Jiajun Liu","doi":"10.1016/j.scr.2025.103731","DOIUrl":null,"url":null,"abstract":"<div><div>The<!--> <!-->anti-CD5 chimeric antigen receptor (CAR)<!--> <!-->is<!--> <!-->a genetically engineered immune cell therapy<!--> <!-->developed<!--> <!-->to target<!--> <!-->CD5-associated<!--> <!-->hematologic malignancies,<!--> <!-->such as<!--> <!-->T-cell lymphoma and leukemia.<!--> <!-->Using<!--> <!-->CRISPR/Cas9-mediated gene targeting, we<!--> <!-->generated<!--> <!-->an<!--> <!-->anti-CD5 CAR knock-in human induced pluripotent stem cell (iPSC) line<!--> <!-->that stably expresses the CAR construct<!--> <!-->and is detectable via FLAG tag and GFP markers. This<!--> <!-->engineered<!--> <!-->cell line<!--> <!-->maintains<!--> <!-->stem cell morphology,<!--> <!-->displays<!--> <!-->a normal karyotype, and<!--> <!-->exhibits robust<!--> <!-->expression of<!--> <!-->pluripotency markers while retaining differentiation potential.</div></div>","PeriodicalId":21843,"journal":{"name":"Stem cell research","volume":"86 ","pages":"Article 103731"},"PeriodicalIF":0.8000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Generation of an anti-CD5 CAR knock-in human induced pluripotent stem cell line using CRISPR/Cas9 technology\",\"authors\":\"Shuoting Wang ,&nbsp;Xinrui Guo ,&nbsp;Han Yan ,&nbsp;Tiancheng Zhou ,&nbsp;Jiajun Liu\",\"doi\":\"10.1016/j.scr.2025.103731\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The<!--> <!-->anti-CD5 chimeric antigen receptor (CAR)<!--> <!-->is<!--> <!-->a genetically engineered immune cell therapy<!--> <!-->developed<!--> <!-->to target<!--> <!-->CD5-associated<!--> <!-->hematologic malignancies,<!--> <!-->such as<!--> <!-->T-cell lymphoma and leukemia.<!--> <!-->Using<!--> <!-->CRISPR/Cas9-mediated gene targeting, we<!--> <!-->generated<!--> <!-->an<!--> <!-->anti-CD5 CAR knock-in human induced pluripotent stem cell (iPSC) line<!--> <!-->that stably expresses the CAR construct<!--> <!-->and is detectable via FLAG tag and GFP markers. This<!--> <!-->engineered<!--> <!-->cell line<!--> <!-->maintains<!--> <!-->stem cell morphology,<!--> <!-->displays<!--> <!-->a normal karyotype, and<!--> <!-->exhibits robust<!--> <!-->expression of<!--> <!-->pluripotency markers while retaining differentiation potential.</div></div>\",\"PeriodicalId\":21843,\"journal\":{\"name\":\"Stem cell research\",\"volume\":\"86 \",\"pages\":\"Article 103731\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem cell research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1873506125000819\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem cell research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1873506125000819","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

抗cd5嵌合抗原受体（CAR）是一种基因工程免疫细胞疗法，用于靶向cd5相关的血液恶性肿瘤，如t细胞淋巴瘤和白血病。利用CRISPR/ cas9介导的基因靶向，我们产生了一种抗cd5 CAR敲入的人诱导多能干细胞（iPSC）系，该系稳定表达CAR构建体，并可通过FLAG标签和GFP标记检测。该工程细胞系保持干细胞形态，显示正常核型，并在保持分化潜力的同时表现出多能性标记的强大表达。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
分享
查看原文 本刊更多论文
Generation of an anti-CD5 CAR knock-in human induced pluripotent stem cell line using CRISPR/Cas9 technology
The anti-CD5 chimeric antigen receptor (CAR) is a genetically engineered immune cell therapy developed to target CD5-associated hematologic malignancies, such as T-cell lymphoma and leukemia. Using CRISPR/Cas9-mediated gene targeting, we generated an anti-CD5 CAR knock-in human induced pluripotent stem cell (iPSC) line that stably expresses the CAR construct and is detectable via FLAG tag and GFP markers. This engineered cell line maintains stem cell morphology, displays a normal karyotype, and exhibits robust expression of pluripotency markers while retaining differentiation potential.
求助全文
通过发布文献求助，成功后即可免费获取论文全文。 去求助
来源期刊
Stem cell research
Stem cell research 生物-生物工程与应用微生物
CiteScore
2.20
自引率
8.30%
发文量
338
审稿时长
55 days
期刊介绍： Stem Cell Research is dedicated to publishing high-quality manuscripts focusing on the biology and applications of stem cell research. Submissions to Stem Cell Research, may cover all aspects of stem cells, including embryonic stem cells, tissue-specific stem cells, cancer stem cells, developmental studies, stem cell genomes, and translational research. Stem Cell Research publishes 6 issues a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信